Quinupristin‐Dalfopristin Resistance in Gram‐Positive Bacteria: Mechanism of Resistance and Epidemiology
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Antimicrobial resistance in gram-positive bacteria is a continuing problem resulting in significant morbidity, mortality, and cost. Because of this resistance, new antimicrobial agents have been needed. Quinupristin-dalfopristin is a recently approved agent for treatment of these infections. Shortly after its introduction into clinical medicine, resistance was reported. Resistance can occur by one or more of several mechanisms, including enzymatic modification, active transport of efflux mediated by an adenosine triphosphate-binding protein, and alteration of the target site. Resistance is rare in isolates of staphylococci and Enterococcus faecium from humans. Resistance is common in isolates recovered from food animals and is related to the use of virginiamicin as a feed additive. Considering the effect antimicrobial resistance has on human health, as well as its economic impact, measures to preserve the usefulness of these agents and delay the development of resistance are urgently needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
An overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
De, N., Rs, K., Rl, L., Chrismon, J. H., Merritt, R., Da, A., & Giovino, G. A. (1994) · PubMed · Cited by 797
Aarestrup, F. M., Seyfarth, A. M., Emborg, H.-D., Pedersen, K., Hendriksen, R. S., & Bager, F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2054-2059.2001 · Cited by 652
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 628
Aarestrup, F. M., Agerso, Y., Gerner–Smidt, P., Madsen, M., & Jensen, L. B. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00130-9 · Cited by 486
Ross, J. I., Eady, E. A., Cove, J. H., Cunliffe, W. J., Baumberg, S., & Wootton, J. C. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00696.x · Cited by 358
vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry
Klare, I. (1995) · FEMS Microbiology Letters · doi:10.1016/0378-1097(94)00493-b · Cited by 326
Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man
LEVY, S. B., FITZGERALD, G. B., & MACONE, A. B. (1976) · Nature · doi:10.1038/260040a0 · Cited by 324
Altered Methylation of Ribosomal RNA in an Erythromycin-Resistant Strain of Staphylococcus aureus
Lai, C. J., & Weisblum, B. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.856 · Cited by 274
Aarestrup, F. M. (1995) · Microbial Drug Resistance · doi:10.1089/mdr.1995.1.255 · Cited by 269
Singh, K. V., Weinstock, G. M., & Murray, B. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1845-1850.2002 · Cited by 263
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1273 · Cited by 230
Macrolide Resistance Genes in Enterococcus spp
Portillo, A., Ruiz-Larrea, F., Zarazaga, M., Alonso, A., Martinez, J. L., & Torres, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.967-971.2000 · Cited by 227
Moellering, R. C., Linden, P. K., Reinhardt, J., Blumberg, E. A., Bompart, F., & Talbot, G. H. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.251 · Cited by 218
Weisblum, B. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.suppl_a.63 · Cited by 196
Inhibition of protein synthesis by streptogramins and related antibiotics
Cocito, C., Di Giambattista, M., Nyssen, E., & Vannuffel, P. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.suppl_1.7 · Cited by 176
(1994) · PsycEXTRA Dataset · doi:10.1037/e546952006-001 · Cited by 174
Aarestrup, F. M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.7.2774-2777.2000 · Cited by 168
Jones, R. N., Ballow, C. H., Biedenbach, D. J., Deinhart, J. A., & Schentag, J. J. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)80002-3 · Cited by 160
Allignet, J., Loncle, V., & Solh, N. E. (1992) · Gene · doi:10.1016/0378-1119(92)90488-b · Cited by 158
Soltani, M., Beighton, D., Philpott‐Howard, J., & Woodford, N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.433-436.2000 · Cited by 147
van den Bogaard, A. E. J. M., Mertens, P., London, N. H., & Stobberingh, E. E. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.454 · Cited by 140
Rende-Fournier, R., Leclercq, R., Galimand, M., Duval, J., & Courvalin, P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2119 · Cited by 127
Hammerum, A. M., Jensen, L. B. ̄. ⁄., & Aarestrup, F. M. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb13267.x · Cited by 111
Allignet, J., Loncle, V., Simenel, C., Delepierre, M., & Solh, N. E. (1993) · Gene · doi:10.1016/0378-1119(93)90350-c · Cited by 110
Allignet, J., & Solh, N. E. (1997) · Gene · doi:10.1016/s0378-1119(97)00464-2 · Cited by 105
Allignet, J., & el Solh, N. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.2027 · Cited by 105
Quinupristin-Dalfopristin–ResistantEnterococcus faeciumon Chicken and in Human Stool Specimens
McDonald, L. C., Rossiter, S., Mackinson, C., Wang, Y. Y., Johnson, S., Sullivan, M. M., Sokolow, R., DeBess, E. E., Gilbert, L., Benson, J. A., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010805 · Cited by 104
Allignet, J., Loncle, V., Mazodier, P., & Solh, N. E. (1988) · Plasmid · doi:10.1016/0147-619x(88)90034-0 · Cited by 91
Werner, G., Klare, I., Heier, H., Hinz, K.-H., BÖHME, G., Wendt, M., & Witte, W. (2000) · Microbial Drug Resistance · doi:10.1089/mdr.2000.6.37 · Cited by 81
Leclercq, R., Nantas, L., Soussy, C., & Duval, J. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.suppl_a.67 · Cited by 75
Allignet, J., Liassine, N., & El Solh, N. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1794 · Cited by 72
Jensen, L. B., Hammerum, A. M., Aarestrup, F. M., van den Bogaard, A. E., & Stobberingh, E. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3330 · Cited by 71
Werner, G., & Witte, W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1813 · Cited by 70
Malbruny, B., Canu, A., Bozdogan, B., Fantin, B., Zarrouk, V., Dutka-Malen, S., Feger, C., & Leclercq, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2200-2207.2002 · Cited by 70
Barrière, J., Bouanchaud, D. H., Paris, J., Rolin, O. Y., Harris, N. V., & Smith, C. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.suppl_a.1 · Cited by 69
Allignet, J., Aubert, S., Morvan, A., & Solh, N. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2523 · Cited by 68
Bozdogan, B., & Leclercq, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2720 · Cited by 65
Mukhtar, T. A., Koteva, K. P., Hughes, D. W., & Wright, G. D. (2001) · Biochemistry · doi:10.1021/bi0106787 · Cited by 61
Dowzicky, M. J., Talbot, G. H., Féger, C., Prokocimer, P., Étienne, J., & Leclercq, R. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00154-6 · Cited by 57
Linkage of vat (E) and erm (B) in Streptogramin-Resistant Enterococcus faecium Isolates from Europe
Jensen, L. B., Hammerum, A. M., & Aarestrup, F. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2231-2232.2000 · Cited by 54
Dina, J., Malbruny, B., & Leclercq, R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2307-2309.2003 · Cited by 53
Aeschlimann, J. R., Zervos, M., & Rybak, M. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2710 · Cited by 50
Self-citationAllignet, J., & Solh, N. E. (1999) · Plasmid · doi:10.1006/plas.1999.1412 · Cited by 50
Simjee, S., White, D. G., Meng, J., Wagner, D. D., Qaiyumi, S., Zhao, S., Hayes, J. R., & McDermott, P. F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf236 · Cited by 50
Haroche, J., Morvan, A., Davi, M., Allignet, J., Bimet, F., & Solh, N. E. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.2.586-591.2003 · Cited by 44
Simjee, S., White, D. G., Wagner, D. D., Meng, J., Qaiyumi, S., Zhao, S., & McDermott, P. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3823-3828.2002 · Cited by 39
Hammerum, A. M., Flannagan, S. E., Clewell, D. B., & Jensen, L. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3223-3225.2001 · Cited by 37
Structure activity relationships in lincosamide and streptogramin antibiotics
Goffic, F. L. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.suppl_a.13 · Cited by 37
Jacobsen, B. L., Skou, M., Hammerum, A. M., & Jensen, L. (1999) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v11i4.8022 · Cited by 36
Plasmid mediated pristinamycin resistance: PH 1A, a pristinamycin 1A hydrolase.
Goffic, F. L., Capmau, M.-L., Abbe, J., Cerceau, C., Dublanchet, A., & Duval, J. (1977) · PubMed · Cited by 36
Concentrations of cefpodoxime in serum and bronchial mucosal biopsies
Baldwin, D., Wise, R., Andrews, J. M., & Honeybourne, D. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.1.67 · Cited by 26
Jacobsen, B. L., Skou, M., Hammerum, A. M., et al. (1999) · Microbial Ecology in Health and Disease · doi:10.1080/089106099435691 · Cited by 21
Zarrouk, V., Bozdoğan, B., Leclercq, R., Garry, L., Carbon, C., & Fantin, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1168-1173.2000 · Cited by 20
Detection of antibiotic resistance genes with DNA probes
Towner, K. J. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.1.1 · Cited by 10
Research works printed but not linked: 9
- Centers, 1994, MMWR Morb Mortal Wkly Rep, 43, 1
- Centers, 1993, MMWR Morb Mortal Wkly Rep, 42, 597
- Zurenko G, Todd WM, Hafkin B, etal Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid [abstract 1105]. In: Program and abstracts or the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1999:727.
- Chabbert YA, 1971, Pathol Biol (Paris), 19, 613
- Angulo F, Marano N, Mackinson C, etal Isolation of quinupristin-dalfopristin resistant Enterococcus faecium from human stool specimens and retail chicken products in the United States [abstract 726]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1999:103.
- Donabedian SM, Perri MB, Bozigar PS, etal Quinupristin-dalfopristin resistance in Enterococcus faecium isolated from humans, farm animals and retail food [abstract C2-1872]. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001:139.
- Perri MB, Donabedian SM, Hershberger E, Zervos MJ. A unique human isolate with the gene conferring vat(E) mediated quinupristin-dalfopristin-resistance in enterococci [abstract C2-1115]. In: Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002:100.
- Le Goffic F, 1977, Ann Microbiol (Paris), 128, 471
- 10.1111/j.1574-6968.1995.tb07353.x · doi:10.1111/j.1574-6968.1995.tb07353.x · Paper page
Cited by
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Antibiotic resistance in Staphylococcus aureus. Current status and future prospects
Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 845
Metadata
- Authors
- Hershberger, E., Donabedian, S., Konstantinou, K., & Zervos, M. J.
- Affiliations
- Wayne State University (US)
- Corresponding author
- Zervos, Marcus J.
- ORCID
- Zervos, Marcus J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01
- Volume
- 38
- Issue
- 1
- Pages
- 92-98
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2073442625
- Cited by
- 156
- References
- 56
- Citations by year
- 2025: 7 · 2024: 7 · 2023: 6 · 2022: 4 · 2021: 9 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 11 · 2016: 2 · 2015: 5 · 2014: 12 · 2013: 5 · 2012: 5
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- quinupristin/dalfopristin, antimicrobial resistance, Gram-positive bacteria, resistance mechanisms, efflux pumps, ABC transporters, enzyme modification, Staphylococcus, Enterococcus faecium, food-producing animals, feed additives, epidemiology of resistance
- MeSH terms
- Anti-Bacterial Agents, Drug Resistance, Gene Frequency, Gram-Positive Bacteria, Humans, Microbial Sensitivity Tests, Virginiamycin, Enterococcus faecium, Health Care Costs, Drug Resistance, Multiple, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.